GHK-Cu has the strongest human evidence
for example, isoniazid, cycloserine, penicillamine, and hydralazine each form complexes with B or otherwise interfere with B metabolism, potentially leading to deficiency and peripheral neuropathy
This aspect is essential for projects requiring extended observation periods or those focused on the effects of sustained peptide administration
Despite its promising therapeutic benefits, the use of the Body Protective Compound 157 requires further research to fully understand the implications and safety profile of the peptide in human medicine
Studies have examined its activity in musculoskeletal tissue models including tendon, ligament, and bone repair research, as well as gastrointestinal cytoprotection and neurological models